HN2008001531A - Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia - Google Patents

Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia

Info

Publication number
HN2008001531A
HN2008001531A HN2008001531A HN2008001531A HN2008001531A HN 2008001531 A HN2008001531 A HN 2008001531A HN 2008001531 A HN2008001531 A HN 2008001531A HN 2008001531 A HN2008001531 A HN 2008001531A HN 2008001531 A HN2008001531 A HN 2008001531A
Authority
HN
Honduras
Prior art keywords
ketorolaco
complex
treatment
neuralgia
combination
Prior art date
Application number
HN2008001531A
Other languages
English (en)
Inventor
Raul Garcia Salgado Lopez Enrique
Barranco Hernandez Gustavo
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2006/004020A external-priority patent/MXPA06004020A/es
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of HN2008001531A publication Critical patent/HN2008001531A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LAS COMBINACIONES FARMACEUTICAS DE SAL DE KETOROLACO Y COMPLEJO B, A METODOS PARA LA FABRICACION DE DICHA COMPOSICIONES Y PARTICULARMENTE A LAS COMBINACIONES SINERGICAS DE KETOROLACO Y COMPLEJO B UTILES PARA TRATMIENTO DE PACIENTES QUE SUFREN DE DOLOR MODERADO A SEVERO Y NEURALGIAS DE DIVERSAS LOCALIZACION
HN2008001531A 2006-04-10 2008-10-10 Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia HN2008001531A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2006/004020A MXPA06004020A (es) 2006-04-10 Composicion farmaceutica que comprende un analgesico y vitaminas

Publications (1)

Publication Number Publication Date
HN2008001531A true HN2008001531A (es) 2011-07-12

Family

ID=38580737

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008001531A HN2008001531A (es) 2006-04-10 2008-10-10 Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia

Country Status (16)

Country Link
US (1) US20090227534A1 (es)
EP (1) EP2008655B1 (es)
JP (1) JP5244089B2 (es)
AR (1) AR060394A1 (es)
BR (1) BRPI0709967A2 (es)
CA (1) CA2649194C (es)
CO (1) CO6331430A2 (es)
CR (1) CR10360A (es)
DO (1) DOP2007000055A (es)
EC (1) ECSP088801A (es)
ES (1) ES2428342T3 (es)
GT (1) GT200800208A (es)
HN (1) HN2008001531A (es)
PE (2) PE20120122A1 (es)
PL (1) PL2008655T3 (es)
WO (1) WO2007116287A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
ES2753981T3 (es) * 2010-10-21 2020-04-15 Rtu Pharmaceuticals Llc Formulaciones de ketorolaco listas para uso
AU2013201465B2 (en) * 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823167A (en) * 1955-03-29 1958-02-11 Vitarine Co Inc Stable vitamin b12-containing solution
FR4492M (es) * 1965-07-07 1966-10-10
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
US6051587A (en) 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
MXPA02010828A (es) 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Also Published As

Publication number Publication date
JP5244089B2 (ja) 2013-07-24
BRPI0709967A2 (pt) 2011-08-02
CO6331430A2 (es) 2011-10-20
ES2428342T3 (es) 2013-11-07
EP2008655A1 (en) 2008-12-31
CA2649194C (en) 2014-12-30
JP2009533413A (ja) 2009-09-17
GT200800208A (es) 2010-03-18
PE20120122A1 (es) 2012-03-09
ECSP088801A (es) 2009-01-30
AR060394A1 (es) 2008-06-11
WO2007116287A1 (es) 2007-10-18
CA2649194A1 (en) 2007-10-18
PL2008655T3 (pl) 2013-11-29
DOP2007000055A (es) 2007-10-31
EP2008655B1 (en) 2013-06-26
US20090227534A1 (en) 2009-09-10
PE20080363A1 (es) 2008-05-25
CR10360A (es) 2009-02-20

Similar Documents

Publication Publication Date Title
HN2010002518A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
GT201400111A (es) Triazolopiridinas sustituidas
DOP2012000150A (es) Triazolopiridinas
DOP2010000118A (es) Compuestos de tienopirimidina y pirazolopirimidina como inhibidores de mtor cinasa y p13 cinasa
PA8660301A1 (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
GT201300254A (es) Triazolopiridinas
DOP2006000096A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
ECSP10010015A (es) Inhibidores de proteasoma
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
ECSP12012338A (es) Triazolopiridinas sustituidas
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
HN2008001531A (es) Composicion farmaceutica que comprenden la combinacion de una sal de ketorolaco y vitamina del complejo b para el tratamiento de la neuralgia
CR10524A (es) Compuesto triciclico y uso farmaceutico del mismo
PA8846401A1 (es) Sinergismo antibiótico
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos
CR9231A (es) Pirroles sustituidos, composiciones que los contienen, procesos de fabricacion y utilizacion
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
CR10382A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR10428A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion